The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_000138.5(FBN1):c.4214T>G (p.Leu1405Arg)

CA014858

200041 (ClinVar)

Gene: FBN1
Condition: Marfan syndrome
Inheritance Mode: Autosomal dominant inheritance
UUID: 39cc6af0-ad57-4b8e-9d7c-c5e6b2348c29
Approved on: 2022-12-01
Published on: 2022-12-01

HGVS expressions

NM_000138.5:c.4214T>G
NM_000138.5(FBN1):c.4214T>G (p.Leu1405Arg)
NC_000015.10:g.48472673A>C
CM000677.2:g.48472673A>C
NC_000015.9:g.48764870A>C
CM000677.1:g.48764870A>C
NC_000015.8:g.46552162A>C
NG_008805.2:g.178116T>G
ENST00000683268.1:n.181T>G
ENST00000684448.1:n.2888T>G
ENST00000316623.10:c.4214T>G
ENST00000316623.9:c.4214T>G
ENST00000537463.6:c.886T>G
NM_000138.4:c.4214T>G

Uncertain Significance

Met criteria codes 1
BS1
Not Met criteria codes 25
PVS1 BA1 BP7 BP5 BP3 BP2 BP4 BP1 BS4 BS3 BS2 PP4 PP1 PP3 PP2 PM6 PM2 PS2 PS4 PS3 PS1 PM4 PM3 PM1 PM5

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
FBN1 VCEP
NM00138 c.4214T>G is a missense variant in FBN1 predicted to cause a substitution of leucine by an arginine at amino acid position 1405. This variant has been reported 14 times in ClinVar: 7 times as likely benign and 7 times as of uncertain significance (Variation ID: 200041). This variant has been reported in the literature and identified by multiple institutions in probands with various features of connective tissue but none with a diagnosis of Marfan syndrome (PMID: 19012347; Mayo Clinic, Bichat Hospital, Universitair Ziekenhuis Gent, Universitair Ziekenhuis Antwerpen). In one family, this variant was found to segregate with mitral valve dystrophy in one family member (Bichat Hospital). This variant has been identified in 0.021% (27/129150) of alleles in the European population in gnomAD v2.1.1 (BS1; https://gnomad.broadinstitute.org/variant/15-48764870-A-C). Computational prediction and evolutionary conservation anaylsis tools are unclear about this variant‘s predicted impact (REVEL = 0.726 which is below 0.750 threshold). Due to there being insufficient evidence, this variant is classified as uncertain significance for Marfan syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen FBN1 VCEP: BS1.
Met criteria codes
BS1
Highest reported MAF: 0.021% [27/129150 European (non-Finnish) alleles]
Not Met criteria codes
PVS1
n/a - variant type
BA1
n/a - BS1 met
BP7
n/a - variant type
BP5
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP3
n/a - variant type
BP2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP4
REVEL = 0.726 (greater than 0.326 threshold)
BP1
n/a for FBN1
BS4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP4
1 proband with SS >7 and EL, no TAAD (does not meet revised Ghent criteria) (same proband cited in PS4 section)
PP1
Identified in 1 proband's (mitral valve dystrophy + moderate skeletal features) father with mitral valve dystrophy (Xavier Bichat-Claude)
PP3
REVEL = 0.726 (less than 0.750 threshold)
PP2
n/a because BS1 criterion is met
PM6
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM2
n/a - BS1 met
PS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS4
n/a because BS1 is met
PS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM4
n/a - variant type
PM3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM5
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.